Alwaleed Philanthropies "Global" in partnership with Bill & Melinda Gates Foundation supports eliminating COVID 19 projects.
In the context of ensuring the safety of the neediest communities, Alwaleed Philanthropies "Global" supported COVID-19 projects in partnership with the Bill and Melinda Gates Foundation.
Objectives
This project in partnership with Bill & Melinda Gates Foundation aims to:
- Supports COVID-19 projects low-cost manufacturing of coronavirus-19 vaccines in low- and middle-income countries,
- Provide treatment accelerators, as well as
- Support Africa Centers for Disease Control and Prevention (CDC) to reach half of all hard-hit countries through capacity-building, additional supplies, technical support, general education, surveillance, and sequencing to monitor disturbing variables.
In partnership with
Combating COVID-19 fund: Diagnostics
Highlights
Duration
2021- 2028
Targeting Group
Sub-Saharan Africa, Latin America, and South Asia
Combating COVID-19 fund: Diagnostics project aims to identify and provide treatments for COVID-19 and deliver them in low- and middle-income countries through access to medical oxygen and to improve patient outcomes and save lives while enabling stronger health systems. Besides, it aims to increase local technical capacity to improve high-flow oxygen delivery systems.
2021 Accomplishments
- Global Access Health has delivered 132,000 test kits to over 10 countries in the Global South, with another 180,000 tests planned for donation.
- Mozambique: (10,000) tests.
- Bangladesh: (82,000) tests.
- Pakistan: (40,000) tests.
- Ethiopia: (40,000) tests, to be shipped.
- Nigeria: (40,000) tests, to be shipped.
- Democratic Republic of Congo: (20,000) tests to be shipped.
- Kenya: (15,000) tests to be shipped.
- Zimbabwe: (15,000) tests, to be shipped.
- South Africa: (10,000 tests) to be shipped.
- Malawi: (10,000) tests, to be shipped.
Combating COVID-19 fund: Therapeutics
Highlights
Duration
2021 - 2023
Targeting Range
Malawi, Sierra Leone, and Guinea-Bissau and Liberia
Combating COVID-19 fund: Therapeutics project aims to identify and provide treatments for COVID-19 and deliver them in low- and middle-income countries through access to medical oxygen and to improve patient outcomes and save lives while enabling stronger health systems. Besides, it aims to increase local technical capacity to improve high-flow oxygen delivery systems.
2021 Accomplishments
- Project implementation has kicked off in 6 out of 9 target cities in Kenya. 4200 of the 6000 targeted community health workers in the 6 cities have been trained on the digital data collection tool. SES data collection has commenced in 2 of the 6 cities.
- Amref is currently working with the 6 cities to set up secure servers where their data can be stored. They are also working with the State Department of Social Protection to enable a push of the collected data into the Government of Kenya’s single register so that it can be easily accessed and help decision-making.
Combating COVID-19 fund: Vulnerable Populations
Highlights
Duration
2021 - 2022
Targeting Range
20-23 African Union member states
Combating COVID-19 fund: Vulnerable Populations project aims to strengthen support for the CDC's response by deploying medical teams to provide medical services to half of the population of countries severely affected by COVID-19 through capacity-building, additional supplies, technical support, public education, surveillance, and sequencing to monitor disturbing variables. It also strengthens capacity and coordination on the ground to detect COVID and ensure equity in global efforts to protect the neediest people.
2021 Accomplishments
- Deploying rapid response teams from Africa CDC to 10 priority countries for 3-to-4-week periods to alleviate immediate needs of member states.
- Recruiting, training, and deploying local rapid response teams for at least three months in up to 10 priority countries.
- Supportive activities for the rapid response teams, including supervision, communications, translation, and PPE.
- Recruiting, training, and deploying community health workers for three months in up to 10 priority countries.
- Expanding or establishing COVID-19 treatment centers across 7-10 countries.
- Strengthening and expanding patient admission and care capacities of COVID-19 treatment centers across 7-10 countries.
